Skip to content
  • Tuesday, 27 October 2026
  • 9:32 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Biohaven and Ono Pharmaceutical Forge Up to $100m Licensing Deal for Advanced IgG Degrader Portfolio in Asia
Pharmaceutical R&D

Biohaven and Ono Pharmaceutical Forge Up to $100m Licensing Deal for Advanced IgG Degrader Portfolio in Asia

Teuku Ryan Oct 11, 2026 0

The global biopharmaceutical landscape witnessed a significant strategic alliance as Biohaven Ltd. announced a landmark licensing and regional partnership agreement…

Read More
Pharmaceutical R&D

Eli Lilly and InnoCare Pharma Forge $3.35bn R&D Partnership to Tackle Oncology and Autoimmune Diseases

Teuku Ryan Sep 27, 2026 0

Eli Lilly and Company has entered into a sweeping, five-drug research and licensing agreement with China-based biopharmaceutical firm InnoCare Pharma,…

Read More
Pharmaceutical R&D

Sandoz and mAbxience Forge Strategic Global Partnership to Develop and Commercialize Emicizumab Biosimilar for Haemophilia A

Teuku Ryan Sep 22, 2026 0

The global pharmaceutical landscape is undergoing a significant shift toward expanded accessibility for complex biologic therapies, highlighted by a major…

Read More
Advanced Materials Science

Virginia Tech Chemists Forge a Sustainable Breakthrough by Upcycling Difficult Plastic Waste into High-Performance Engine Lubricants

Nila Kartika Wati Sep 16, 2026 0

The global crisis of plastic pollution has long defied simple solutions, particularly regarding polyvinyl chloride, widely known as PVC. Unlike…

Read More
Pharmaceutical R&D

Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease

Teuku Ryan Jul 24, 2026 0

Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…

Read More
Pharmaceutical R&D

UK and Switzerland Forge Landmark Free Trade Agreement, Cementing Pharmaceutical Intellectual Property Protections

Teuku Ryan Jul 17, 2026 0

The United Kingdom and Switzerland have finalized a groundbreaking free trade agreement that explicitly enshrines intellectual property (IP) protections for…

Read More
Pharmaceutical R&D

Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease

Teuku Ryan Jun 28, 2026 0

Ionis Pharmaceuticals has forged a significant global licensing agreement with Recordati, a prominent international pharmaceutical company, granting Recordati exclusive rights…

Read More
Pharmaceutical R&D

Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases

Teuku Ryan Jun 27, 2026 0

Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…

Read More
Pharmaceutical R&D

Eli Lilly and Oura Health Forge Strategic Alliance to Pioneer Integrated Obesity Care

Teuku Ryan Jun 25, 2026 0

The landscape of obesity treatment is undergoing a profound transformation, moving beyond purely pharmaceutical interventions to embrace a holistic ecosystem…

Read More
Pharmaceutical R&D

Novartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets

Teuku Ryan Jun 24, 2026 0

In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…

Read More

Posts pagination

1 2 … 4
The Hidden Rhythm of Performance: How Respiratory Cycles Influence Human Reaction TimesDoherty Institute researchers unveil an assay that identifies four STIs and antibiotic resistance in under an hour with up to 100% precision.Tau Protein Essential for Long-Term Memory Stabilization and Engram Cell Organization in the BrainIsland Wolves Rewrite Ancient Human-Wolf Dynamics
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ